Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

HDFC Life Insurance Company - Not only - but also - about protection - ICICI Securities

Posted On: 2021-01-24 22:17:11 (Time Zone: Arizona, USA)


A weaker retail protection performance in Q3FY21 (down 17%/28% YoY/QoQ) has been well managed through improvement in segments like ULIP, credit protect and non-par/participating savings. As such, HDFC Life's (HDLI) 9MFY21 VNB is flat YoY at Rs14.1bn, which we think is a commendable performance given the impact of Covid. Growth levers ahead include: 1) ULIP revival, 2) improvement in credit protection, and 3) new protection product launched in Q4FY21.

- Is dip in retail protection a concern? Not really, considering that protection demand was weak at the industry level in Q3FY21. However, HDLI has ably managed to balance this with growth in other segments (Q3FY21 total APE ex-protection growth of >22% YoY).

- Volume growth and credit life offset the dip in retail protection to maintain VNB margins: ULIP APE has improved from Rs2.9bn in Q1FY21 to Rs3.6bn in Q2FY21 and Rs4.2bn in Q3FY21. Credit protect (NBP basis) has also witnessed steady recovery from Rs2.4bn in Q1FY21 to Rs7bn in Q2FY21 and Rs10bn in Q3FY21. Total protection grew at a marginal rate of 1% in Q3FY21 as sharp fall in retail protection (48% YoY) got offset with robust growth in group protection (39% YoY). Retail/group protection APE was Rs1.2bn/Rs0.4bn in Q1FY21, Rs.4bn/Rs1.1bn in Q2FY21 and Rs0.7bn/ Rs2.4bn in Q3FY21. Basis total APE, individual non-par savings has grown 6% /(-)32% in Q3/9MFY21, par savings has grown 122%/186% in Q3FY21/9MFY21 while annuity has grown 49%/33% in Q3/9MFY21. Operating performance has improved with persistency improving in 4 out of 5 cohorts while the 9MFY21 cost ratio ((commission + Operating expenses)/ total premium (including renewals)) stood at 16% which is lower than 18.5% in 9MFY20.

- Banca has been a clear outperformer, agency picking up: Banca individual APE has progressively grown to Rs6.3bn/10.7bn/8.6bn in Q1/Q2 /Q3FY21 while agency APE has clocked Rs1.3bn/2.4bn/2.8bn during the respective periods.

- New product launched in protection: This is a term plan that provides flexibility to auto balance death and critical illness cover or receive income payouts from age 60. This product has already been launched and can result in growth in protection/margin in H1CY21. Evolving trends have favoured protection products with some form of added saving elements and this product can fit well in that format.

- Downgrade from Buy to ADD. We factor VNB margin of 26.4/28/30% with APE growth of 3%/18/15% in FY21E/FY22E/FY23E. We expect HDLI to accumulate Rs54bn of new business and Rs41bn of unwind (@ 7.5%) over FY22E/FY23E to reach Embedded Value (EV) of Rs348bn by FY23E. We value HDLI based on 40x new business value of Rs30bn in FY23E to arrive at the target price of Rs767. At our target price, HDLI will trade at 4.4x FY23E P/EV.

Shares of HDFC Life Insurance Company Ltd was last trading in BSE at Rs.687.65 as compared to the previous close of Rs. 700.65. The total number of shares traded during the day was 169948 in over 8946 trades.

The stock hit an intraday high of Rs. 708.3 and intraday low of 684.25. The net turnover during the day was Rs. 117781926.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Wipro - Beware of integration / impairment risks! - ICICI Securities

Easy Trip Planners Ltd - IPO Review - ICICI Direct

ICICI Direct - Derivatives Weekly View (March 5): Level of 14700 remains crucial for upsides to continue...

Easy Trip Planners Ltd. - IPO - Strong Financials - Reliance Securities

Bharat Forge - Initiating Coverage - Constant evolution - HDFC Securities

Mahindra Logistics - Large-ticket deal win - ICICI Securities

Company Update - Huhtamaki India - ICICI Direct

Gladiator Stocks: IndusInd Bank, VIP Industries - ICICI Direct

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020